Prim's (BME:PRM) Solid Profits Have Weak Fundamentals
Sep 17
Have your own idea? Try our Stock Screener
Spanish (IBEX) Healthcare Sector Analysis
UpdatedOct 01, 2025
DataAggregated Company Financials
Companies12
- 7D2.5%
- 3M11.4%
- 1Y18.1%
- YTD21.8%
The Healthcare industry has been flat over the last week, but Oryzon Genomics has lost 6.0%. The past year has been better, since the industry has gained 16% in that time. Earnings are forecast to grow by 29% annually.
Sector Valuation and Performance
Has the Spanish Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 02 Oct 2025 | €17.4b | €11.1b | €621.8m | 25.3x | 28x | 1.6x |
| Sat, 30 Aug 2025 | €17.1b | €11.1b | €610.7m | 25.1x | 28x | 1.5x |
| Mon, 28 Jul 2025 | €17.1b | €11.0b | €503.5m | 21.2x | 33.9x | 1.6x |
| Wed, 25 Jun 2025 | €15.6b | €11.0b | €507.4m | 21.4x | 30.7x | 1.4x |
| Fri, 23 May 2025 | €15.2b | €11.0b | €507.1m | 22.6x | 29.9x | 1.4x |
| Sun, 20 Apr 2025 | €13.5b | €10.8b | €458.2m | 19.6x | 29.4x | 1.2x |
| Tue, 18 Mar 2025 | €14.9b | €10.8b | €458.8m | 19.9x | 32.4x | 1.4x |
| Thu, 13 Feb 2025 | €14.4b | €10.6b | €392.4m | 17.1x | 36.7x | 1.4x |
| Sat, 11 Jan 2025 | €14.4b | €10.6b | €392.4m | 19.7x | 36.8x | 1.4x |
| Mon, 09 Dec 2024 | €14.2b | €10.6b | €392.5m | 19.7x | 36.2x | 1.3x |
| Wed, 06 Nov 2024 | €16.1b | €10.3b | €391.6m | 24.5x | 41.1x | 1.6x |
| Fri, 04 Oct 2024 | €15.4b | €10.2b | €394.8m | 15.1x | 38.9x | 1.5x |
| Sun, 01 Sep 2024 | €15.5b | €10.2b | €399.9m | 14.9x | 38.7x | 1.5x |
| Tue, 30 Jul 2024 | €15.4b | €10.0b | €412.0m | 20.1x | 37.5x | 1.5x |
| Thu, 27 Jun 2024 | €15.0b | €10.0b | €405.8m | 19.8x | 36.8x | 1.5x |
| Sat, 25 May 2024 | €15.5b | €10.0b | €396.3m | 19.3x | 39.1x | 1.5x |
| Mon, 22 Apr 2024 | €13.6b | €10.0b | €297.6m | 17.4x | 45.7x | 1.4x |
| Wed, 20 Mar 2024 | €13.2b | €10.0b | €289.0m | 20.9x | 45.5x | 1.3x |
| Fri, 16 Feb 2024 | €14.7b | €10.0b | €331.9m | 18.2x | 44.4x | 1.5x |
| Sun, 14 Jan 2024 | €13.5b | €10.0b | €332.6m | 17.2x | 40.5x | 1.3x |
| Tue, 12 Dec 2023 | €16.2b | €10.0b | €332.5m | 17.1x | 48.7x | 1.6x |
| Thu, 09 Nov 2023 | €14.5b | €9.9b | €311.1m | 16.2x | 46.5x | 1.5x |
| Sat, 07 Oct 2023 | €14.8b | €9.8b | €302.1m | 18.6x | 48.8x | 1.5x |
| Mon, 04 Sep 2023 | €15.4b | €9.8b | €311.0m | 19.4x | 49.5x | 1.6x |
| Wed, 02 Aug 2023 | €15.1b | €9.8b | €311.0m | 21.3x | 48.6x | 1.6x |
| Fri, 30 Jun 2023 | €13.4b | €9.6b | €364.5m | 18.9x | 36.7x | 1.4x |
| Sun, 28 May 2023 | €13.7b | €9.6b | €366.5m | 21.7x | 37.4x | 1.4x |
| Tue, 25 Apr 2023 | €12.5b | €9.3b | €566.0m | 17.8x | 22.1x | 1.3x |
| Thu, 23 Mar 2023 | €12.0b | €9.3b | €564.2m | 18.9x | 21.2x | 1.3x |
| Sat, 18 Feb 2023 | €15.8b | €8.4b | €430.5m | 13.5x | 36.7x | 1.9x |
| Mon, 16 Jan 2023 | €14.6b | €8.4b | €430.6m | 14.1x | 34x | 1.7x |
| Wed, 14 Dec 2022 | €13.8b | €8.4b | €431.5m | 13.9x | 31.9x | 1.6x |
| Fri, 11 Nov 2022 | €13.2b | €8.3b | €460.8m | 14.1x | 28.7x | 1.6x |
| Sun, 09 Oct 2022 | €12.8b | €8.4b | €462.3m | 13.3x | 27.6x | 1.5x |
Price to Earnings Ratio
27.6x
Current Industry PE
- Investors are pessimistic on the Spanish Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 28.0x which is lower than its 3-year average PE of 37.0x.
- The industry is trading close to its 3-year average PS ratio of 1.5x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 10% per year over the last three years.
- Revenues for these companies have grown 9.9% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Spanish Healthcare sector?
| ES Market | 2.34% | |
| Healthcare | 2.48% | |
| Pharma | 3.21% | |
| Biotech | 2.38% | |
| Life Sciences | 0.57% | |
| Medical Equipment | -1.12% | |
| Healthcare Services | -1.21% | |
Industry PE
- Investors are most optimistic about the Healthcare Services industry which is trading above its 3-year average PE ratio of 39.5x.
- Analysts are expecting annual earnings growth of 123.2%, which is higher than its past year's earnings growth of 1.7% per year.
Forecasted Growth
- Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 123% over the next 5 years.
- This is better than its past earnings growth rate of 1.7% per year.
- In contrast, the Pharma industry is expected to see its earnings grow by 23% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| GRF Grifols | €12.43 | 1.5% +€125.9m | 23.7% | PE28.4x | |
| PHM Pharma Mar | €94.85 | 8.0% +€121.5m | 103.5% | PE39.2x | |
| ROVI Laboratorios Farmaceuticos Rovi | €59.80 | 3.0% +€89.5m | -16.4% | PE23.1x | |
| ALM Almirall | €11.84 | 3.1% +€77.3m | 31.8% | PE119.2x | |
| FAE Faes Farma | €4.36 | 3.2% +€42.0m | 18.2% | PE12.9x |